Showing 2 posts of 2 posts found.

Biogen Phase III choroideremia study did not meet primary endpoint

June 15, 2021
Manufacturing and Production Biogen, choroideremia, phase III

Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …

NHS image

Gene trial ‘restores sight’

January 17, 2014
Research and Development, Sales and Marketing NHS, Oxford University Hospitals NHS Trust, choroideremia, eyes

A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …

Latest content